FSGEX | RIGEX | FSGEX / RIGEX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 15 years | 16 years | - |
Gain YTD | 6.931 | 4.983 | 139% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 48.2B | 15B | 321% |
Annual Yield % from dividends | 2.77 | 2.32 | 119% |
Returns for 1 year | 13.05 | 10.23 | 127% |
Returns for 3 years | 4.21 | -4.62 | -91% |
Returns for 5 years | 27.61 | 15.01 | 184% |
Returns for 10 years | 46.75 | 15.61 | 299% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FTXH | 28.09 | 0.31 | +1.11% |
First Trust Nasdaq Pharmaceuticals ETF | |||
ACTV | 33.45 | 0.33 | +1.01% |
LeaderShares® Activist Leaders® ETF | |||
FTCS | 92.82 | 0.65 | +0.71% |
First Trust Capital Strength ETF | |||
PID | 19.28 | 0.10 | +0.52% |
Invesco International Div Achiev ETF | |||
ICLO | 25.61 | 0.01 | +0.04% |
Invesco AAA CLO Floating Rate Note ETF |